(1)
The Impact of Immune Checkpoint Inhibitors-Induced Skin Toxicity on Patients’ Quality of Life and the Role of Dermatologic Intervention. Dermatol Pract Concept 2024, 14 (3), e2024118. https://doi.org/10.5826/dpc.1403a118.